Leveraging RWD to Support Drug Assay Development in Molecular Oncology
Sponsored content for QIAGEN by BioPharma Dive's Brand Studio
Duration: 1 hour
Although precision oncology has made rapid progress over the past few years, many questions remain. What answers lie in our DNA, and how can drug developers use that information to develop clinical trial protocols?
Join us to discuss the impact of real-world data on molecular oncology. This webinar will cover:
How customers can leverage real-world data in clinical and scientific settings.
Tips for using data to support biomarker selection decisions for diagnostic assays
Real world examples and case studies
Sheryl Krevsky Elkin, PhD Chief Scientific Officer
N-of-One, a QIAGEN company
Copyright 2019 Industry Dive
Form submitted successfully.
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing the on-demand webinar.